Search Count: 6
 |
Cdk2/Cycline Bound To Compound 11 With P-Loop In The Ee And Cc Conformations
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2025-04-30 Classification: CELL CYCLE Ligands: A1CAE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2025-04-30 Classification: CELL CYCLE Ligands: A1CAH |
 |
Cdk2/Cycline Bound To Compound 19 With P-Loop In The Ee And Ec Conformations
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2025-04-30 Classification: CELL CYCLE Ligands: A1CAF |
 |
Cdk2/Cycline Bound To Compound 20 With P-Loop In The Ee And Cc Conformations
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2025-04-30 Classification: CELL CYCLE Ligands: A1CAG |
 |
Cdk2/Cycline Bound To Compound 21 With P-Loop In The Ee And Cc Conformations
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-04-30 Classification: CELL CYCLE Ligands: A1CAI |
 |
Discovery And Clinical Validation Of Rly-4008, The First Highly Selective Fgfr2 Inhibitor With Activity Across Fgfr2 Alterations And Resistance Mutations
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.79 Å Release Date: 2023-06-07 Classification: TRANSFERASE/INHIBITOR Ligands: WCJ |